4//SEC Filing
Huizinga Robert Bindert 4
Accession 0001628280-21-018595
CIK 0001600620other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:12 PM ET
Size
7.4 KB
Accession
0001628280-21-018595
Insider Transaction Report
Form 4
Huizinga Robert Bindert
EVP of Research
Transactions
- Sale
Common Stock
2021-09-10$19.83/sh−5,000$99,150→ 133,592 total - Sale
Common Stock
2021-09-10$19.76/sh−5,000$98,800→ 128,592 total - Sale
Common Stock
2021-09-14$21.75/sh−22,500$489,375→ 106,092 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001837648
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 5:12 PM ET
- Size
- 7.4 KB